Use of statins and risk of glioma: a nationwide case-control study in Denmark

被引:42
作者
Gaist, D. [1 ]
Andersen, L. [1 ]
Hallas, J. [2 ]
Sorensen, H. Toft [3 ]
Schroder, H. D. [4 ]
Friis, S. [5 ,6 ]
机构
[1] Univ Southern Denmark, Odense Univ Hosp, Inst Clin Res, Dept Neurol,Fac Hlth Sci, DK-5000 Odense C, Denmark
[2] Univ Southern Denmark, Inst Publ Hlth, DK-5000 Odense C, Denmark
[3] Aarhus Univ Hosp, Dept Clin Epidemiol, DK-8200 Aarhus N, Denmark
[4] Odense Univ Hosp, Inst Clin Res, Dept Pathol, DK-5000 Odense C, Denmark
[5] Univ Copenhagen, Danish Canc Soc Res Ctr, DK-2100 Copenhagen O, Denmark
[6] Univ Copenhagen, Dept Publ Hlth, DK-2100 Copenhagen O, Denmark
关键词
glioma; statins; brain tumour epidemiology; HUMAN GLIOBLASTOMA CELLS; DANISH CANCER REGISTRY; INDUCED APOPTOSIS; LOVASTATIN; SIMVASTATIN; INHIBITION; MIGRATION; PROLIFERATION; POPULATION; TUMORS;
D O I
10.1038/bjc.2012.536
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Laboratory studies and a single case-control study have suggested a protective effect of statins on the risk of glioma. We wished to investigate the influence of statin use on the risk of glioma in a population-based setting. Methods: We conducted a nationwide case-control study in Denmark based on population-based medical registries. We identified all patients aged 20 to 85 years with a first diagnosis of histologically verified glioma during 2000-2009. These cases were matched on birth year and sex with population controls. Prior use of statins since 1995 was classified into short-term use (<5 years) and long-term use (5+ years). We used conditional logistic regression to compute odds ratios (ORs), with 95% confidence intervals (CIs), for glioma associated with statin use, adjusted for potential confounders. Results: A total of 2656 cases and 18 480 controls were included in the study. The risk of glioma was reduced among long-term statin users (OR = 0.76; 95% CI: 0.59-0.98) compared with never users of statins, and was inversely related to the intensity of statin treatment among users (OR = 0.71; 95% CI: 0.44-1.15 for highest intensity). The inverse association between long-term statin treatment and glioma risk was more pronounced among men aged <= 60 years (OR = 0.40; 95% CI: 0.17-0.91) compared with men aged 60+ years (OR = 0.71; 95% CI: 0.49-1.03). An inverse association was also observed among women aged <= 60 years (OR = 0.28; 95% CI: 0.06-1.25), but not among women over age 60 years (OR = 1.23; 95% CI: 0.82-1.85). Conclusion: Long-term statin use may reduce the risk of glioma.
引用
收藏
页码:715 / 720
页数:6
相关论文
共 37 条
[1]   Danish registers on aspects of reproduction [J].
Blenstrup, Lene Tolboll ;
Knudsen, Lisbeth B. .
SCANDINAVIAN JOURNAL OF PUBLIC HEALTH, 2011, 39 :79-82
[2]   Brain tumor epidemiology: Consensus from the Brain Tumor Epidemiology Consortium [J].
Bondy, Melissa L. ;
Scheurer, Michael E. ;
Malmer, Beatrice ;
Barnholtz-Sloan, Jill S. ;
Davis, Faith G. ;
Il'Yasova, Dora ;
Kruchko, Carol ;
McCarthy, Bridget J. ;
Rajaraman, Preetha ;
Schwartzbaum, Judith A. ;
Sadetzki, Siegal ;
Schlehofer, Brigitte ;
Tihan, Tarik ;
Wiemels, Joseph L. ;
Wrensch, Margaret ;
Buffler, Patricia A. .
CANCER, 2008, 113 (07) :1953-1968
[3]   CONCENTRATIONS OF PRAVASTATIN AND LOVASTATIN IN CEREBROSPINAL-FLUID IN HEALTHY-SUBJECTS [J].
BOTTI, RE ;
TRISCARI, J ;
PAN, HY ;
ZAYAT, J .
CLINICAL NEUROPHARMACOLOGY, 1991, 14 (03) :256-261
[4]   Statin use and cancer risk: a comprehensive review [J].
Boudreau, Denise M. ;
Yu, Onchee ;
Johnson, Jeanene .
EXPERT OPINION ON DRUG SAFETY, 2010, 9 (04) :603-621
[5]  
Bouterfa HL, 2000, ANTICANCER RES, V20, P2761
[6]   Cancer occurrence in Danish diabetic patients: duration and insulin effects [J].
Carstensen, B. ;
Witte, D. R. ;
Friis, S. .
DIABETOLOGIA, 2012, 55 (04) :948-958
[7]   Lovastatin sensitized human glioblastoma cells to TRAIL-induced apoptosis [J].
Chan, David Y. L. ;
Chen, George G. ;
Poon, Wai S. ;
Liu, Pi C. .
JOURNAL OF NEURO-ONCOLOGY, 2008, 86 (03) :273-283
[8]  
Chan KKW, 2003, CLIN CANCER RES, V9, P10
[9]  
Csizmadi I, 2005, PHARMACOEPIDEMIOLOGY, 4TH EDITION, P791
[10]   HMG CoA reductase inhibitors, NSAIDs and risk of glioma [J].
Ferris, Jennifer S. ;
McCoy, Lucie ;
Neugut, Alfred I. ;
Wrensch, Margaret ;
Lai, Rose .
INTERNATIONAL JOURNAL OF CANCER, 2012, 131 (06) :E1031-E1037